Mdma molecule:

Image from PubChem

Mdma Clinical Trials

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

To see complete record on, please visit this link

Id: NCT05286879

Organisation Name: Yale University

Overal Status: Recruiting

Start Date: March 31, 2022

Last Update: April 8, 2022

Lead Sponsor: Yale University

Brief Summary: This is a 5-year Hybrid Type 1 Effectiveness-Implementation Randomized Control Trial (RCT) that compares two models of linking and retaining individuals recently released from custody to the continuum of community-based HIV and opioid use disorder (OUD) prevention and treatment, medication for opioid use disorder (MOUD) service cascades of care.

  • Opioid Use Disorder
  • Infectious Disease
  • Risk Reduction Behavior
  • Substance Use
  • Substance Abuse
  • Stimulant Use Disorder

Total execution time in seconds: 0.28715991973877